Page last updated: 2024-09-04

docetaxel anhydrous and theophylline

docetaxel anhydrous has been researched along with theophylline in 3 studies

Compound Research Comparison

Studies (docetaxel anhydrous)	Trials (docetaxel anhydrous)	Recent Studies (post-2010) (docetaxel anhydrous)	Studies (theophylline)	Trials (theophylline)	Recent Studies (post-2010) (theophylline)
12,110	3,216	6,920	20,076	1,612	1,383

Protein Interaction Comparison

Protein	Taxonomy	docetaxel anhydrous (IC50)	theophylline (IC50)
Adenosine receptor A1	Bos taurus (cattle)		2.43

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Boggs, JW; Choo, EF; Deng, Y; Hop, CE; McNamara, E; Messick, K; West, K	1

Reviews

1 review(s) available for docetaxel anhydrous and theophylline

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

2 other study(ies) available for docetaxel anhydrous and theophylline

Article	Year
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Assessment of the hepatic CYP reductase null mouse model and its potential application in drug discovery. Molecular pharmaceutics, 2014, Mar-03, Volume: 11, Issue:3 Topics: Animals; Antineoplastic Agents; Cytochrome P-450 Enzyme System; Docetaxel; Drug Discovery; Female; Fibrosarcoma; Hypnotics and Sedatives; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Midazolam; NADPH-Ferrihemoprotein Reductase; Taxoids; Theophylline; Vasodilator Agents	2014

Article

Year

A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.

Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013

Assessment of the hepatic CYP reductase null mouse model and its potential application in drug discovery.

Molecular pharmaceutics, 2014, Mar-03, Volume: 11, Issue:3

Topics: Animals; Antineoplastic Agents; Cytochrome P-450 Enzyme System; Docetaxel; Drug Discovery; Female; Fibrosarcoma; Hypnotics and Sedatives; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Midazolam; NADPH-Ferrihemoprotein Reductase; Taxoids; Theophylline; Vasodilator Agents

2014